|
| Risk of PD in patients with T2DM | Authors | Sample |
|
| Increased (n = 9) | De Pablo-Fernandez et al. [20] | T2DM: 2,017,115
Controls: 6,173,208 |
| | De Pablo-Fernandez et al. [43] | PD: 79 (14 with T2DM)
Controls: 4.919 (842 with T2DM) |
| | Yang et al. [44] | T2DM: 36.294 (550 with PD)
Controls: 108.882 (1232 with PD) |
| | Yue et al. [45] | PD: 6441
Controls: 1.755.191 |
| | Sun et al. [46] | T2DM: 603.413 (1.613 with PD)
Controls: 472.718 (809 with PD) |
| | Wahlqvist et al. [47] | T2DM: 64.166
Controls: 698.587 |
| | Schernhammer [48] | PD: 1.931 (126 with T2DM)
Controls: 9.651 (482 with T2DM) |
| | Xu et al. [49] | T2DM: 21.611 (172 with PD)
Controls: 267.051 (1393 with PD) |
| | Hu et al. [19] | T2DM: 1.098 (24 with PD)
Controls: 50.454 (609 with PD) |
|
| Decreased (n = 5) | Miyake et al. [50] | PD: 249 (10 with T2DM)
Controls: 368 (39 with T2DM) |
| | D′ Amelio et al. [51] | PD: 318 (13 with T2DM)
Controls: 318 (31 with T2DM) |
| | Leibson et al. [52] | PD: 197 (18 with T2DM)
Controls: 197 (24 with T2DM) |
| | Powers et al. [53] | PD: 352 (26 with T2DM)
Controls: 484 (61 with T2DM) |
| | Herishanu et al. [54] | PD: 93 (11 with T2DM)
Controls: 93 (26 with T2DM) |
|
| Not related (n = 4) | Savica et al. [22] | PD: 196 (13 with T2DM)
Controls: 196 (17 with T2DM) |
| | Palacios et al. [55] | PD: 656
Controls: 147,440 |
| | Driver et al. [56] | PD: 556
Controls: 21.285 |
| | Simon et al. [57] | PD: 530 (37 with T2DM)
Controls: 171.349 (3.722 with T2DM) |
|
| Risk of T2DM in patients with PD | | |
| Decreased (n = 2) | Becker et al. [58] | PD: 3.637 (291 with T2DM)
Controls: 3.637 (308 with T2DM) |
| | Scigliano et al. [59] | PD: 178 (6 with T2DM)
Controls: 534 (58 with T2DM) |
| Increased (n = 1) | Pressley et al. [60] | PD: 791 (235 with T2DM)
Controls: 24.040 (5.175 with T2DM) |
| Total = 21 | | |
|
